Arbutus Biopharma Corp (ABUS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 921.59M |
| Enterprise Value | 907.77M |
| P/E Ratio | 5.63 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 4.84 |
| Price/Book Ratio | 3.4 |
| Enterprise/Revenue | 4.75 |
| Enterprise/EBITDA | 5.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.84 |
| Operating Margin | 0.81 |
| Return On Assets | 0.56 |
| Return On Equity | 0.91 |
| Revenue | 14.08M |
| Revenue/Share | 0.92 |
| Gross Profit | 13.72M |
| EBITDA | -33.04M |
| Net Income | -33.5M |
| Diluted EPS | -0.17 |
| Total Cash | 92.63M |
| Total Cash/Share | 0.47 |
| Total Debt | 3.63M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 81.42 |
| Book Value Per Share | 1.31 |
| 52-Week Change | -0.89 |
| 52-Week High | 5.45 |
| 52-Week Low | 3.5 |
| Moving Average 50 Days | 4.83 |
| Moving Average 200 Days | 4.54 |
| Average Volume | 4.48M |
| Shares Outstanding | 197.54M |
| % Held by Institutions | 71.93 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | November 04, 2010 |